Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
RYM.NZ
SELLGet insider-trade alertsRyman Healthcare Limited · Healthcare · New Zealand · $1.3B · Avg Vol: $2M/d
25
StockRankQ
29
V
34
M
50
P/E (TTM)
—
ROE
-4.1%
D/E
1.9x
Dividend %
—
COMPANY DESCRIPTION
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 284.2M | 316.0M | 367.0M | 402.7M | 12.3% |
| EPS | 0.69 | 0.26 | 0.00 | -0.35 | -92.7% |
| Shares | 563.5M | 730.4M | 730.4M | 1.0B | +80.3% |
| Debt | 1.9B | 1.3B | 1.4B | 956.3M | -20.6% |
| Equity | 1.9B | 2.6B | 2.5B | 2.4B | 7.5% |
| Op CF | — | — | — | — | — |
| Inv CF | -444.1M | -586.6M | -475.0M | -296.5M | — |
| Fin CF | 118.2M | 219.2M | 111.4M | 51.4M | — |
Loading...
PRICE (1Y)+7.0%
SMA 50SMA 200
Close
$1.29
RSI (14)
50.0
52W High
$1.72
From 52W High
0.7%
SCORE BREAKDOWN
Quality
29
ROIC
-0.7%43.5
ROE
-4.1%39.9
GP/Assets
0.7%11.9
Op. Margin
5.3%55.6
FCF/Assets
-0.8%42.2
Piotroski
211.9
Int. Cover
-0.5x35.4
D/E Ratio
1.90x6.3
Current Ratio
1.33x20.3
Value
34
P/E (TTM)
—N/A
EV/EBITDA
129.0x3.7
P/FCF
—N/A
P/B
0.6x93.9
P/S
2.7x57.9
Div Yield
—N/A
Momentum
50
52W High %
75%64.2
RS 6M
-21%50.7
SMA 50/200
0.87x26.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+137%80.5
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$1.3B
P/E (Forward)
12.7x
Gross Margin
9.5%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of RYM.NZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| RYM.NZ | Ryman Healthcare Limited(you) | $1.3B | 25 | SELL |
| SNZ.AX | Summerset Group Holdings Limited | $1.2B | 26 | SELL |
| OCA.NZ | Oceania Healthcare Limited | $304M | 37 | HOLD |
| RAD.NZ | Radius Residential Care Limited | $62M | 96 | STRONG BUY |
| PEB.NZ | Pacific Edge Limited | $210M | 29 | SELL |
| ARX.AX | Aroa Biosurgery Limited | $141M | 59 | HOLD |
| AFT.NZ | AFT Pharmaceuticals Limited | $218M | 78 | BUY |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $12.8B | 83 | STRONG BUY |
| GXH.NZ | Green Cross Health Limited | $159M | 99 | STRONG BUY |
Peer medians: ROE 11.0% · P/E 20.1x · Gross margin 34.0%